BBIO - BridgeBio Pharma GAAP EPS of -$1.08 misses by $0.27 revenue of $4.09M misses by $0.4M
2023-11-02 08:11:29 ET
More on BridgeBio Pharma
- BridgeBio: Bets Acoramidis As The Pfizer Spoiler
- BridgeBio: Positive Updated Acoramidis Data May Not Imply Further Upside
- BridgeBio draws Buy rating at Cantor citing 100% upside
- BridgeBio Pharma to issue 9.2M shares through PIPE financing
- Seeking Alpha’s Quant Rating on BridgeBio Pharma
For further details see:
BridgeBio Pharma GAAP EPS of -$1.08 misses by $0.27, revenue of $4.09M misses by $0.4M